Therapeutic Solutions International (TSOI) Stock Price, News & Analysis

Company Overview

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) is a clinical-stage biotechnology company focused on discovering, developing and commercializing innovative small-molecule therapeutics for the treatment of cancer, neurological disorders and inflammatory diseases. The company’s core expertise lies in medicinal chemistry and preclinical pharmacology, enabling the advancement of multiple proprietary drug candidates from early discovery through regulatory submission. TSOI’s pipeline includes lead compounds designed to target key molecular pathways implicated in tumor growth and neurodegeneration, as well as novel anti-inflammatory agents aimed at chronic conditions with high unmet medical needs.

Since its founding in 2011, TSOI has established research operations in Tampa, Florida, with satellite laboratories in Austin, Texas, and collaborative partnerships with academic institutions in North Carolina’s Research Triangle. These geographic footprints support both in-house discovery work and external contract research activities, including formulation development and toxicology testing. The company maintains strategic alliances with university spin-outs and contract research organizations to accelerate candidate validation and manufacturing scale-up ahead of human clinical trials.

Under the leadership of CEO and Board Chairman George Massimi, who brings over two decades of experience in life-sciences management and drug development, Therapeutic Solutions International has grown its executive team to include seasoned experts in clinical operations, regulatory affairs and business development. CEO Massimi is supported by Chief Scientific Officer Dr. Jeanette Gomez, whose background in kinase biology has guided the design of TSOI’s oncology compounds, and CFO Kyle Smith, who oversees financial planning and strategic investor relations. Together, this leadership cadre continues to drive the company’s mission to create differentiated therapeutics that address significant global healthcare challenges.

Key Stats

• Today's Range: $0.0001 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0009
• Volume: 5.88 million shs
• Average Volume: 25.63 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Therapeutic Solutions International Stock Analysis - MarketRank™

Therapeutic Solutions International scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Therapeutic Solutions International.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Therapeutic Solutions International is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Therapeutic Solutions International is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Therapeutic Solutions International has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Therapeutic Solutions International has recently decreased by 99.87%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Therapeutic Solutions International does not currently pay a dividend.

Dividend Growth

Therapeutic Solutions International does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Therapeutic Solutions International has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Therapeutic Solutions International has recently decreased by 99.87%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: N/A

News Sentiment

Therapeutic Solutions International has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Therapeutic Solutions International insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 5.62% of the stock of Therapeutic Solutions International is held by institutions.

TSOI Stock Analysis - Frequently Asked Questions

How have TSOI shares performed this year?

Therapeutic Solutions International's stock was trading at $0.0002 on January 1st, 2025. Since then, TSOI shares have decreased by 50.0% and is now trading at $0.0001.

How do I buy shares of Therapeutic Solutions International?

Shares of TSOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Therapeutic Solutions International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Therapeutic Solutions International investors own include Creative Medical Technology (CELZ), Hon Hai Precision Industry Co., Ltd. Sponsored GDR (HNHPF), Zevra Therapeutics (ZVRA), CAS Medical Systems (CASM), CRISPR Therapeutics (CRSP), Trevena (TRVN) and Alamos Gold (AGI).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:TSOI
• CIK: 1419051
• Web: therapeuticsolutionsint.com
• Phone: (760) 295-7208
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A